Tubal Ligation
Conditions
Brief summary
Today tubal sterilization is a simple, safe, and cost-effective method of achieving long-term contraception. Sterilization is an ideal method of permanent contraception in developing countries where access to health care providers is limited. The percentage of women who use sterilization as a method of contraception rises from about 5% between 20 and 24 years of age to almost 50% for those between 40 and 44 years of age. The most widely touted and most significant health benefit of tubal sterilization appears to be a reduced risk of ovarian cancer. Post-tubal ligation syndrome includes pain during intercourse, aching lower back, premenstrual tension syndrome, uterine hemorrhage, and absence of menstruation. The syndrome is caused by blood circulation problems in and around the Fallopian tubes and ovaries, pressure on nerves, and intrapelvic adhesion. Since the symptoms of this syndrome are mild, simple symptomatic treatment is sufficient in most cases. In some cases, however, hysterectomy may be necessary.
Interventions
Levonorgestrel-releasing intrauterine system will be inserted during the menstrual cycle
Sponsors
Assiut University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
30 Years to 45 Years
Healthy volunteers
No
Inclusion criteria
* Women aged from 30-40 year * Woman subjected to tubal ligation * Women 12 month postpartum * Non lactating women * Nomedical disorders
Exclusion criteria
* contraindication for Levonorgestrel-releasing Intrauterine System * Women with any uterine or ovarian pathology * women refuse to participate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The level of pain from before to 6 months after levonorgestrel-releasing intrauterine system insertion | 6 months | visual analogue scale from 0 (minimum value) to 10 (maximum value) |
Countries
Egypt
Outcome results
None listed